Virtual healthcare platform Induction has completed the acquisition of video health consultation provider Attend Anywhere in a £16.35m deal.
The sum includes around £790k for Attend Anywhere’s net assets upon completion of the deal.
Commenting on the deal, James Balmain, joint CEO of Induction, said the deal was the latest development in the firm’s journey to provide a comprehensive virtual care platform for hospitals, doctors and patients.
“Attend Anywhere extends our existing product set with a mature video consultation platform already being widely used by NHS hospitals across the UK,” he said.
“Critically, it will also deliver Attend Anywhere customers an even higher standard of user support, technical resilience and customer service, via our existing UK based infrastructure.”
He noted that Induction products will now cover pre-treatment patient support and the full range of in-person, telephone and live-video consultations.
Hugo Stephenson, joint CEO Induction, added: “I am delighted to welcome Attend Anywhere CEO Chris Ryan and his team to be part of the exciting future for Induction as we work together to create an all-encompassing virtual care platform that can be used at scale so that our healthcare systems can work better.
“We are very pleased with the support from existing and new investors and we look forward to updating shareholders as we deliver on our integration plan and growth strategy.
“We are particularly excited about taking a UK platform, used at scale, and exploring its potential in new markets that look to the UK as a digital exemplar, and face similar challenges dealing with long waiting lists and limited space for seeing patients as healthcare systems try to open up after vaccination roll-outs.”
Attend Anywhere CEO Chris Ryan said: “The Attend Anywhere model for mainstream, business-as-usual video consultations for health services has been proven at scale.
“We see a great many synergies with the Induction team, its ethos, products and services. This includes accelerating the development of integrated solutions and services that underpin modern health care delivery, and expanding our operational capabilities and footprint in the UK and in Europe as well as Australia, Asia and elsewhere.”
